|
Impact of lenalidomide-bortezomib-dexamethasone (RVd) induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect MM Registry. |
|
|
Consulting or Advisory Role - Amgen; Celgene; Janssen Biotech; Takeda |
Research Funding - Celgene (Inst); Cellectar (Inst); Janssen Biotech (Inst); Pharmacyclics (Inst); Phosplatin Therapeutics (Inst) |
Travel, Accommodations, Expenses - Amgen; Novartis; Takeda |
|
|
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda |
Research Funding - Amgen; Celgene; Daiichi Sankyo; GlaxoSmithKline; Janssen; Takeda |
|
|
Honoraria - Celgene; Janssen; Takeda |
Consulting or Advisory Role - celgene; Janssen; Takeda |
Travel, Accommodations, Expenses - Celgene; Janssen; Takeda |
|
|
Consulting or Advisory Role - Celgene |
|
|
|
|
|
Honoraria - Bristol-Myers Squibb; Janssen; Takeda |
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Janssen; Karyopharm Therapeutics; Precision Biosciences |
Speakers' Bureau - Celgene; Karyopharm Therapeutics |
Research Funding - Celgene |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen |
|
|
No Relationships to Disclose |
|
|
|
|
|
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda |
|
|
|
Consulting or Advisory Role - Celgene |
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Johnson & Johnson |
|
|
Consulting or Advisory Role - Celgene |
Speakers' Bureau - Janssen Oncology |
|
|
Consulting or Advisory Role - Celgene |
Travel, Accommodations, Expenses - Celgene |
|
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
|
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
|
|
|
Stock and Other Ownership Interests - Bristol-Myers Squibb |
|
|
Consulting or Advisory Role - Celgene; Janssen Oncology; Takeda |
Research Funding - Janssen (Inst) |